跳转到主要内容
搜索

Vaccines play a crucial role in preventing diseases and thereby saving countless lives. To prevent the spread of diseases, it is important that vaccines are broadly available in all parts of the world. However, the development of vaccines is expensive and time-consuming, limiting the availability of vaccines. We use our Vaccine Model to predict optimal dosing schemes for clinical trials in both adult and paediatric populations. We demonstrate how our Vaccine Model could have supported vaccine development for SARS-Cov-2 to reduce cost and time and could have been used to prevent costly trial extensions.

Authors: Manon Wigbers, Dennis Reddyhoff, Rachel Rose, Rajat Desikan, Piet H. van der Graaf, Andrzej Kierzek

Learn more about Quantitative Systems Pharmacology

By examining interactions between drugs, biological systems, and diseases, QSP offers a robust framework for predicting clinical outcomes, optimizing therapeutic strategies, and streamlining decision-making. Certara’s regulatory-ready platforms support reproducible model development across various therapeutic areas, including oncology, inflammation and immunology, and neurodegenerative diseases.

View QSP softwareView QSP Consulting

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software